DiabetesNCT01297387
Feasibility of Peripheral Angioplasty in Type D TASCII Lesions
An observational study of Diabetes and Critical Limb Ischemia, run by IRCCS Multimedica at 1 site in Italy.
Trial summary
This observational prospective study will evaluate, according o usual local clinical practice, feasibility of endoluminal revascularization in diabetic patients with type C and D lesions, according to TASC II Criteria. About 300 patients will be treated with usual revascularization procedure. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Diabetes, Critical Limb Ischemia
- What is being tested?
- PTA BPG procedure,
- How many people
- 344 participants
- Where
- 1 siteItaly
- Study dates
- Jan 2009to Dec 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Diabetic patients with critical limb ischemia
Who may be able to join
- Adult diabetic patients type 1 or 2
- Chronic critical ischemia as defined by TASC 2007 criteria (pain at rest, and/or ulcer or gangrene due to arteriopathy: transcutaneous oximetry < 30 mmHg or pressure on the ankle < 70 mmHg)
Who cannot join
- Cancer with adverse prognosis in months, or chemotherapeutic treatment
- Ongoing or planned pregnancy
- Lack of consent to participate to the study
Trial locations and contacts
1 site in 1 country.
Italy1 site
Diabetic Foot Center IRCCS MultiMedica
Sesto San Giovanni, Milano, 20099
About this study
Official title: An Observational, Prospective Study Evaluating Feasibility of Peripheral Angioplasty in Diabetic Patients With Critical Limb Ischemia in C and D Obstructions of Transatlantic Inter-Society Consensus (TASC II).
This observational prospective study will evaluate, according o usual local clinical practice, feasibility of endoluminal revascularization in diabetic patients with type C and D lesions, according to TASC II Criteria.
About 300 patients will be treated with usual revascularization procedure. Each patient will be followed at least 12 months to evaluate clinical outcome and limb salvage interventions.
Read the detailed description
In 2000, the Trans Atlantic Inter-Society Consensus (TASC) stated that patients with CLI should be treated with revascularization, to provide sufficient blood flow to relieve the rest pain and heal skin lesions. TASC also suggested that the best procedure should avoid a general anaesthesia, pose a lesser systemic stress and have fewer serious complications.
All these considerations pose peripheral angioplasty (PTA) as the procedure of choice, when feasible.
Unfortunately, TASC Recommendations, published in 2000 and confirmed in 2007, use morphological criteria to define guidelines for the choice of revascularization procedure.
According to these recommendations, type C and D lesions, which comprise most serious stenosis and occlusions, affecting long tracts of vessels, are candidate to bypass interventions, more than PTA.
This choice was due to the first impression, then denied by BASIL study, that PTA could be affected by a reduced efficacy on limb salvage.
Diabetic Patients are characterized by high prevalence of long occlusions in crural arteries and this anatomical asset reduces, according to TASC II criteria, the feasibility of Bypass Graft (BPG) in a large number of such patients.
Our preliminary experience showed the feasibility of PTA in diabetic patients with Chronic Critical Limb Ischemia (CLI), with a high percentage of efficient revascularization, regardless of morphology and number of obstructions.
This study aims to evaluate outcomes after PTA procedure also in patients with lesions of 20 cm or longer in superficial femoral arteries or with "long lesions" in subpopliteal arteries.
All diabetic patients referring to our Diabetic Foot Centre either for foot lesions or rest pain will be assessed for the presence of Critical Limb Ischemia (CLI) according to TASC II Criteria.
These patients, according to usual local clinical practice, will undergo to angiographic evaluation and, if feasible, to peripheral angioplasty.
The peripheral pulses will be evaluated by palpation and auscultation with a continuous-wave Doppler technique, the ankle-pressure will be recorded, when assessable (foot arteries absent or not compressible because of medial calcifications), the transcutaneous oxygen tension (TcPO2) will be evaluated at the dorsum of the foot and a duplex scanning will be performed. In all patients with one reduced or absent foot pulse, TcPO2 < 50 mmHg, ankle-pressure < 70 mmHg, significant obstructions present at duplex scanning, an arteriography will be carried out. In all patient with obstruction > 50% of vessel diameter, PTA will be the first-choice revascularization procedure and will be performed in the same session of the angiographic study. In patients in whom PTA will not be feasible, a by-pass operation was considered. The patients in whom PTA or BPG were not possible, received a therapy with prostanoids or lumbar sympathectomy plus prostanoids, when possible. In patients in whom the therapies did not relieve the rest pain or the gangrene was extended above the Chopart joint, an above-the-ankle-amputation was proposed and performed.
PTA procedure PTA was considered indicated for angiographically documented obstructions greater than 50% of the vessel lumen. The procedures were performed under local anesthesia through antegrade puncture of the ipsilateral common femoral artery. If obstructions were present in the iliac trunk at duplex scanning, the puncture was performed by contralateral approach. Vessel recanalization was considered successful when direct flow was obtained in treated vessel, with no residual stenosis > 50% of vessel diameter along the artery.
BPG procedure The choice of proximal and distal BPG anastomoses depended on the angiographic picture and aimed at obtaining at least one patent foot artery. The inflow was optimized, when possible, by combining femoral-popliteal bypass and PTA of the iliac trunk. Moreover, also in view of a following distal angioplasty, the distal anastomosis was performed on the most suitable popliteal or tibial artery segment by using intraluminal clamping and microsurgical technique. The surgery has always been carried out under epidural anesthesia. The autogenous saphena vein was employed if present and in good condition. If venous conduit could not be used, alloplastic prosthetic material (polytetrafluoroethylene: PTFE) was employed and the peripheral below-the-knee anastomosis consisted of a venous cuff using the Miller's technique, or "composite" bypass with interposition of distal venous segments. The absence of an available saphena and an angiographic score of run off >7 on the Rutherford scale did not exclude any patient, who otherwise could be eligible only for a major amputation, from a revascularization with distal bypass.
Treatment of non revascularized patients Prostanoids (alprostadil-α-cyclodextrine 60-120 μgr/day) were infused intravenously on average 5 days before hospital discharge. When possible and accepted by the patients, lumbar sympathectomy was performed.
In all patients the pain change was recorded and the TcPO2 and ankle-pressure values were reassessed 5 days after the PTA, BPG, lumbar sympathectomy and medical therapy.
Limb salvage In patients complaining of rest pain without foot ulcer, the disappearance of pain was considered to be a successful limb salvage. In patients with foot ulcer we considered limb salvage successful when the ulcer was healed and plantar stand was maintained, even when achieved by tarsal-metatarsal amputation and the patient is able to walk without crutches or artificial leg. Conversely, any above-the-ankle amputation was considered a failure. Limb salvage was considered early when pain disappeared and ulcer healed in 30 days after hospital admission.
Follow-up After hospital discharge All the patients with foot ulcer were examined weekly until ulcer healing. All patients were provided with extra-deep rocker shoes with soft thermoformable leather and customized insoles.
Evidence of PTA restenosis was assessed clinically only, based on pain reappearance or ulcer recurrence. In these situations ankle-pressure and TcPO2 were reassessed and duplex scanning was performed (22). If ankle pressure and TcPO2 were significantly worse (<15% of the post-PTA value) and Duplex scanning was positive, the patient underwent a repeated angiographic evaluation and a further PTA, if possible. Morphological restenosis was not investigated: in absence of rest pain or ulcer reappearance we do not perform any revascularization (23), therefore we consider the morphological restenosis clinically irrelevant.
BPG treated patients were followed with vascular surgery protocol (24). The graft patency was assessed with clinical examination and ultrasound study at 30 days, 3,6,12 months and thereafter every 6 months. Pulse systolic velocity and anastomosis morphology were assessed by ultrasound study. Finally, inflow is compared with pre-operative condition.
For every invasive treatment (PTA, BPG, sympathectomy, surgical operation on the foot) the written informed consent form was proposed and obtained from the patient.
- Conditions
- Diabetes, Critical Limb Ischemia
- Being tested
- PTA BPG procedure,
- Keywords
- Diabetic Patients, Critical Limb Ischemia, Revascularization
- Medical subject headings
- Diabetes Mellitus, Chronic Limb-Threatening Ischemia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PTA BPG procedure,Other
Also called Peripheral angioplasty
Surgery PTA or BPG Procedure, according usual local clinical practice
| Study group | Role | What they receive |
|---|---|---|
| Revascularization of limb ischemia | Procedure/Surgery Receives: Other: PTA BPG procedure, |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Feb 2011 (estimated)
- Study startJan 2009
- Study completionDec 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DiabetesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 344 participants (actual)
Sponsor and investigators
- Lead sponsor
- IRCCS Multimedica
- Sponsor type
- University, hospital or other
- Investigators
- Ezio Faglia, MD, Principal investigator, Diabetic Foot Centre IRCCS MultiMedica
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01297387
- Sponsor's protocol ID
- 08/2007_Cardiovascolare
- Status last verified
- Feb 2011
- First submitted
- 15 Feb 2011
- Last updated
- 21 Feb 2011
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Feb 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Observational, Prospective Study Evaluating Feasibility of Peripheral Angioplasty in Diabetic Patients With Critical Limb Ischemia in C and D Obstructions of Transatlantic Inter-Society Consensus (TASC II).
- ClinicalTrials.gov ID
- NCT01297387
- Acronym / sponsor ID
- 08/2007_Cardiovascolare
- Conditions
- Diabetes, Critical Limb Ischemia
- Keywords
- Diabetic Patients, Critical Limb Ischemia, Revascularization
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 344 participants (actual)
- Lead sponsor
- IRCCS MultimedicaUniversity, hospital or other
- Study start
- Jan 2009
- Study completion
- Dec 2009 (actual)
- First posted
- 16 Feb 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This observational prospective study will evaluate, according o usual local clinical practice, feasibility of endoluminal revascularization in diabetic patients with type C and D lesions, according to TASC II Criteria.
About 300 patients will be treated with usual revascularization procedure. Each patient will be followed at least 12 months to evaluate clinical outcome and limb salvage interventions.
Detailed description
In 2000, the Trans Atlantic Inter-Society Consensus (TASC) stated that patients with CLI should be treated with revascularization, to provide sufficient blood flow to relieve the rest pain and heal skin lesions. TASC also suggested that the best procedure should avoid a general anaesthesia, pose a lesser systemic stress and have fewer serious complications.
All these considerations pose peripheral angioplasty (PTA) as the procedure of choice, when feasible.
Unfortunately, TASC Recommendations, published in 2000 and confirmed in 2007, use morphological criteria to define guidelines for the choice of revascularization procedure.
According to these recommendations, type C and D lesions, which comprise most serious stenosis and occlusions, affecting long tracts of vessels, are candidate to bypass interventions, more than PTA.
This choice was due to the first impression, then denied by BASIL study, that PTA could be affected by a reduced efficacy on limb salvage.
Diabetic Patients are characterized by high prevalence of long occlusions in crural arteries and this anatomical asset reduces, according to TASC II criteria, the feasibility of Bypass Graft (BPG) in a large number of such patients.
Our preliminary experience showed the feasibility of PTA in diabetic patients with Chronic Critical Limb Ischemia (CLI), with a high percentage of efficient revascularization, regardless of morphology and number of obstructions.
This study aims to evaluate outcomes after PTA procedure also in patients with lesions of 20 cm or longer in superficial femoral arteries or with "long lesions" in subpopliteal arteries.
All diabetic patients referring to our Diabetic Foot Centre either for foot lesions or rest pain will be assessed for the presence of Critical Limb Ischemia (CLI) according to TASC II Criteria.
These patients, according to usual local clinical practice, will undergo to angiographic evaluation and, if feasible, to peripheral angioplasty.
The peripheral pulses will be evaluated by palpation and auscultation with a continuous-wave Doppler technique, the ankle-pressure will be recorded, when assessable (foot arteries absent or not compressible because of medial calcifications), the transcutaneous oxygen tension (TcPO2) will be evaluated at the dorsum of the foot and a duplex scanning will be performed. In all patients with one reduced or absent foot pulse, TcPO2 < 50 mmHg, ankle-pressure < 70 mmHg, significant obstructions present at duplex scanning, an arteriography will be carried out. In all patient with obstruction > 50% of vessel diameter, PTA will be the first-choice revascularization procedure and will be performed in the same session of the angiographic study. In patients in whom PTA will not be feasible, a by-pass operation was considered. The patients in whom PTA or BPG were not possible, received a therapy with prostanoids or lumbar sympathectomy plus prostanoids, when possible. In patients in whom the therapies did not relieve the rest pain or the gangrene was extended above the Chopart joint, an above-the-ankle-amputation was proposed and performed.
PTA procedure PTA was considered indicated for angiographically documented obstructions greater than 50% of the vessel lumen. The procedures were performed under local anesthesia through antegrade puncture of the ipsilateral common femoral artery. If obstructions were present in the iliac trunk at duplex scanning, the puncture was performed by contralateral approach. Vessel recanalization was considered successful when direct flow was obtained in treated vessel, with no residual stenosis > 50% of vessel diameter along the artery.
BPG procedure The choice of proximal and distal BPG anastomoses depended on the angiographic picture and aimed at obtaining at least one patent foot artery. The inflow was optimized, when possible, by combining femoral-popliteal bypass and PTA of the iliac trunk. Moreover, also in view of a following distal angioplasty, the distal anastomosis was performed on the most suitable popliteal or tibial artery segment by using intraluminal clamping and microsurgical technique. The surgery has always been carried out under epidural anesthesia. The autogenous saphena vein was employed if present and in good condition. If venous conduit could not be used, alloplastic prosthetic material (polytetrafluoroethylene: PTFE) was employed and the peripheral below-the-knee anastomosis consisted of a venous cuff using the Miller's technique, or "composite" bypass with interposition of distal venous segments. The absence of an available saphena and an angiographic score of run off >7 on the Rutherford scale did not exclude any patient, who otherwise could be eligible only for a major amputation, from a revascularization with distal bypass.
Treatment of non revascularized patients Prostanoids (alprostadil-α-cyclodextrine 60-120 μgr/day) were infused intravenously on average 5 days before hospital discharge. When possible and accepted by the patients, lumbar sympathectomy was performed.
In all patients the pain change was recorded and the TcPO2 and ankle-pressure values were reassessed 5 days after the PTA, BPG, lumbar sympathectomy and medical therapy.
Limb salvage In patients complaining of rest pain without foot ulcer, the disappearance of pain was considered to be a successful limb salvage. In patients with foot ulcer we considered limb salvage successful when the ulcer was healed and plantar stand was maintained, even when achieved by tarsal-metatarsal amputation and the patient is able to walk without crutches or artificial leg. Conversely, any above-the-ankle amputation was considered a failure. Limb salvage was considered early when pain disappeared and ulcer healed in 30 days after hospital admission.
Follow-up After hospital discharge All the patients with foot ulcer were examined weekly until ulcer healing. All patients were provided with extra-deep rocker shoes with soft thermoformable leather and customized insoles.
Evidence of PTA restenosis was assessed clinically only, based on pain reappearance or ulcer recurrence. In these situations ankle-pressure and TcPO2 were reassessed and duplex scanning was performed (22). If ankle pressure and TcPO2 were significantly worse (<15% of the post-PTA value) and Duplex scanning was positive, the patient underwent a repeated angiographic evaluation and a further PTA, if possible. Morphological restenosis was not investigated: in absence of rest pain or ulcer reappearance we do not perform any revascularization (23), therefore we consider the morphological restenosis clinically irrelevant.
BPG treated patients were followed with vascular surgery protocol (24). The graft patency was assessed with clinical examination and ultrasound study at 30 days, 3,6,12 months and thereafter every 6 months. Pulse systolic velocity and anastomosis morphology were assessed by ultrasound study. Finally, inflow is compared with pre-operative condition.
For every invasive treatment (PTA, BPG, sympathectomy, surgical operation on the foot) the written informed consent form was proposed and obtained from the patient.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Revascularization of limb ischemia | – | Other: PTA BPG procedure,Procedure/Surgery |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Diabetic patients with critical limb ischemia
Key inclusion criteria (2 listed)
- Adult diabetic patients type 1 or 2
- Chronic critical ischemia as defined by TASC 2007 criteria (pain at rest, and/or ulcer or gangrene due to arteriopathy: transcutaneous oximetry < 30 mmHg or pressure on the ankle < 70 mmHg)
Key exclusion criteria (3 listed)
- Cancer with adverse prognosis in months, or chemotherapeutic treatment
- Ongoing or planned pregnancy
- Lack of consent to participate to the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PTA BPG procedure,Also: Peripheral angioplastySurgery PTA or BPG Procedure, according usual local clinical practice | Other | Revascularization of limb ischemia |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Feb 2011.
Related trials for Diabetes
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ezio Faglia, MD principal investigator
Diabetic Foot Centre IRCCS MultiMedica
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Diabetes and Critical Limb Ischemia, run by IRCCS Multimedica at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Feb 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2011.